PLG and neoplasm: The beneficial actions of TA in inhibiting Plasmin activation and activity in the cancer setting are well appreciated, but to our knowledge, the present study is the first to survey the effects of TA on an array of other signaling pathways and proteins with roles in tumor growth and progression.